BackNuvectis Pharma Overview

Nuvectis Pharma Other Liabilities

Latest other liabilities for NVCT: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Nuvectis Pharma Other Liabilities History

Loading

Nuvectis Pharma vs. peers: Other Liabilities Comparison

Loading

Nuvectis Pharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nuvectis Pharma (NVCT) FAQ

As of the most recent data (March 2026), NVCT shows a other liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVCT's other liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Nuvectis Pharma is outperforming or lagging.

Tracking NVCT's other liabilities over time shows whether Nuvectis Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Nuvectis Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.